Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × UNKNOWN × Growth Hormone × Clear all

Phase

Status

Sponsor Class

UNKNOWN 1 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Dwarfism 1

Interventions

toripalimab 1 pegylated granulocyte colony-stimulating factor 1 Idarubicin 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Growth Hormone 1 Cytarabine 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01901666 2013-07-17

Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission

PIMERIndia

Phase 4 Unknown

MyeloidOther hematologic neoplasm

Dwarfism, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡